
Avalglucosidase alfa-ngpt is an enzyme replacement therapy that reduces glycogen accumulation.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Avalglucosidase alfa-ngpt is an enzyme replacement therapy that reduces glycogen accumulation.

The new diet program was compared to the existing front-line therapy of exclusive enteral nutrition.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

Fecal microbiota transplantation could be crucial in the coming years in treating C difficile infections.

The COVID-19 pandemic may have exposed more disparities based on race or ethnicity in ADHD care.

IBD patients were less likely to have diets that regularly include vegetables, cereals, breads, and diary.

The cumulative time to curative treatment failure rates of patients who received DAA were 93.6% and 73.2% at 1 and 3 years, respectively.

The platform leverages optical coherence tomography and Ultreon Software.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Italy and the Netherlands both achieved their target HBV control.

Infants between 6-12 months old had the highest prevalence of C difficile detection.

Severe mental disorders had the highest odds ratios for the risk of mortality.

The FDA approved selexipag tablets for PAH in 2015.

For only reward learning, anhedonia was associated with model-derived learning parameters and neural learning signals.

There was no association found between migraines and Crohn’s disease or ulcerative colitis.

The company expects to continue to study the potential inflammatory bowel disease treatment.

Genotype F was the common genotype found at 5.73 per 1000 person-years of follow-up.

Patients with IBD, rheumatoid arthritis, and psoriasis are commonly treated using biologic agents such as infliximab, tofacitinib, and ustekinumab.

Exenatide extended-release represents the first regulatory approval for a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) for pediatric patients with type 2 diabetes.

The treatment was associated with an increased risk of C difficile colitis.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

CBGT and MBSR were both associated with a significant decrease in negative emotion.

A recent study has found statins are underutilized for NASH and NAFLD patients.

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

The rare liver disease can often lead to liver failure.

The researchers found sero-protection rate at 12-month was significantly higher in the ID arm compared to the IM cohort.

The treatment met all 5 primary efficacy endpoints as part of the ASCEND program.

This patient group was at an increased risk for future exposure to systemic corticosteroids and anti-TNF biologics.

The FDA Cardiovascular and Renal Drugs Advisory Committee cited concerns over an increase in thrombotic events.

Biologic use was not associated with an increased risk of hepatitis B virus flares.